Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: A randomized cross-over study

被引:9
作者
Keller-Hamilton, Brittney [1 ,2 ,5 ]
Alalwan, Mahmood A. [2 ]
Curran, Hayley [2 ]
Hinton, Alice [2 ,3 ]
Long, Lauren [2 ]
Chrzan, Kirsten [2 ,3 ]
Wagener, Theodore L. [1 ,2 ]
Atkinson, Leanne [2 ,3 ]
Suraapaneni, Sriya [2 ,4 ]
Mays, Darren [2 ]
机构
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Ctr Tobacco Res, Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA
[4] Ohio State Univ, Coll Arts & Sci, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Ctr Tobacco Res, 3650 Olentangy River Rd, Columbus, OH 43214 USA
基金
美国国家卫生研究院;
关键词
Cigarettes; health disparities; misuse liability; nicotine; oral nicotine pouches; rural; TOBACCO PRODUCTS; CANCER INCIDENCE; MORTALITY;
D O I
10.1111/add.16355
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and aims: Oral nicotine pouches (ONPs) probably offer reduced harm compared with cigarettes, but independent data concerning their misuse liability are lacking. We compared nicotine delivery and craving relief from ONPs with different nicotine concentrations to cigarettes.Design: This was a single-blind, three-visit (>= 48-hour washout), randomized-cross-over study. Participants were encouraged to complete all study visits in less than 1 month.Setting: The study took place in Rural/Appalachian Ohio.Participants: Participants comprised 30 adults who smoke cigarettes. Participants (mean(age) = 34.5) were 60% men and 90% White.Intervention: Participants who were >= 12-hour tobacco-abstinent used: (1) a 3-mg nicotine concentration ONP, (2) a 6-mg nicotine concentration ONP and (3) usual brand cigarette in separate visits. ONPs (wintergreen Zyn) were used for 30 minutes; cigarettes were puffed every 30 sec for 5 minutes.Measurements: Plasma nicotine and self-reported craving were assessed at t = 0, 5, 15, 30, 60 and 90 minutes. The primary outcome was plasma nicotine concentration at t = 30 minutes. A secondary outcome was craving relief at t = 5 minutes.Findings: At t = 30, mean [95% confidence interval (CI)] plasma nicotine was 9.5 ng/ml (95% CI = 7.1, 11.9 ng/ml) for the 3 mg nicotine ONP, 17.5 ng/ml (95% CI = 13.7, 21.3) for the 6 mg nicotine ONP and 11.4 ng/ml (95% CI = 9.2, 13.6 ng/ml) for the cigarette. Mean plasma nicotine at t = 30 minutes differed between the 3- and 6-mg nicotine ONPs (P = 0.001) and between the 6-mg nicotine ONP and cigarette (P = 0.002). Mean (95% CI) craving at t = 5 minutes was lower for the cigarette (mean = 1.00, 95% CI = 0.61, 1.39) than either the 3 mg (mean = 2.25, 95% CI = 1.68, 2.82; P < 0.0001) or 6 mg nicotine (mean = 2.19, 95% CI = 1.60, 2.79; P < 0.0001) ONP.Conclusions: Among adult smokers, using 6-mg nicotine concentration oral nicotine pouches (ONPs) was associated with greater plasma nicotine delivery at 30 minutes than 3-mg ONPs or cigarettes, but neither ONP relieved craving symptoms at 5 minutes as strongly as a cigarette. Accelerating the speed of nicotine delivery in ONPs might increase their misuse liability relative to cigarettes.
引用
收藏
页码:464 / 475
页数:12
相关论文
共 46 条
  • [1] 111th Congress US Government Printing Office [organization], HR 1256 111 C FAM SM
  • [2] Preliminary Validity of the Modified Cigarette Evaluation Questionnaire in Predicting the Reinforcing Effects of Cigarettes That Vary in Nicotine Content
    Arger, Christopher A.
    Heil, Sarah H.
    Sigmon, Stacey C.
    Tidey, Jennifer W.
    Stitzer, Maxine L.
    Gaalema, Diann E.
    Durand, Hanna J.
    Bunn, Janice Y.
    Ruggieri, Elizabeth K.
    Higgins, Stephen T.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 25 (06) : 473 - 478
  • [3] Harm Reduction Associated with Dual Use of Cigarettes and e-Cigarettes in Black and Latino Smokers: Secondary Analyses from a Randomized Controlled e-Cigarette Switching Trial
    Arnold, Michael J.
    Nollen, Nicole L.
    Mayo, Matthew S.
    Ahluwalia, Jasjit S.
    Leavens, Eleanor L.
    Zhang, Guanlin
    Rice, Myra
    Pulvers, Kim
    [J]. NICOTINE & TOBACCO RESEARCH, 2021, 23 (11) : 1972 - 1976
  • [4] Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers
    Azzopardi, David
    Haswell, Linsey E.
    Frosina, Justin
    McEwan, Michael
    Gale, Nathan
    Thissen, Jesse
    Meichanetzidis, Filimon
    Hardie, George
    [J]. BIOMARKERS, 2023, 28 (01) : 118 - 129
  • [5] Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums
    Azzopardi, David
    Liu, Chuan
    Murphy, James
    [J]. DRUG AND CHEMICAL TOXICOLOGY, 2022, 45 (05) : 2246 - 2254
  • [6] Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
    Back, Susanne
    Masser, Anna E.
    Rutqvist, Lars E.
    Lindholm, Johan
    [J]. BMC CHEMISTRY, 2023, 17 (01)
  • [7] The Central Role of pH in the Clinical Pharmacology of Nicotine: Implications for Abuse Liability, Cigarette Harm Reduction and FDA Regulation COMMENT
    Benowitz, Neal L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (05) : 1004 - 1006
  • [8] Nicotine Addiction
    Benowitz, Neal L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) : 2295 - 2303
  • [9] Cancer Mortality Rates in Appalachia: Descriptive Epidemiology and an Approach to Explaining Differences in Outcomes
    Blackley, David
    Behringer, Bruce
    Zheng, Shimin
    [J]. JOURNAL OF COMMUNITY HEALTH, 2012, 37 (04) : 804 - 813
  • [10] Blake KD, 2017, CANCER EPIDEM BIOMAR, V26, P992, DOI [10.1158/1055-9965.EPI-17-0092, 10.1158/1055-9965.epi-17-0092]